Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters
Phase of Trial: Phase IV
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Adverse reactions; Therapeutic Use
- 31 Oct 2017 Status changed from not yet recruiting to recruiting.
- 25 Sep 2017 Planned End Date changed from 1 Aug 2018 to 1 Oct 2018.
- 25 Sep 2017 Planned primary completion date changed from 1 Feb 2018 to 1 May 2018.